FIGHT-202: A phase II study of pemigatinib in patients (pts) with previously treated locally advanced or metastatic cholangiocarcinoma (CCA) Meeting Abstract
| Authors: | Vogel, A.; Sahai, V.; Hollebecque, A.; Vaccaro, G.; Melisi, D.; Al-Rajabi, R.; Paulson, A. S.; Borad, M. J.; Gallinson, D.; Murphy, A. G.; Oh, D. Y.; Dotan, E.; Catenacci, D. V.; Van Cutsem, E.; Lihou, C. F.; Zhen, H.; Féliz, L.; Abou-Alfa, G. K. |
| Abstract Title: | FIGHT-202: A phase II study of pemigatinib in patients (pts) with previously treated locally advanced or metastatic cholangiocarcinoma (CCA) |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz394.031 |
| Language: | English |
| ACCESSION: | WOS:000491295500164 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz394.031 |
| Notes: | Meeting Abstract: LBA40 -- Appears on page v876 of the abstract book -- Source: Wos |
